Carcinogenic products and regions of incidence

Código BFNP-E0039-I

Visualizações: 1385   Data: 2020-03-20

List of Classifications by cancer sites with sufficient or limited evidence in humans, Volumes 1 to 124 a

Cancer site

Carcinogenic agents with sufficient evidence in humans

Agents with limited evidence in humans

Mesothelium (pleura and peritoneum)

Asbestos (all forms) Erionite Fluoro-edenite Painting

Endothelium (Kaposi sarcoma)

Human immunodeficiency virus type 1 Kaposi sarcoma herpes virus

Soft tissue

Polychlorophenols or their sodium salts (combined exposures)

Radioiodines, including iodine-131

2,3,7,8-Tetrachlorodibenzo-

para-dioxin

Breast and female genital organs

Breast

Alcoholic beverages Diethylstilbestrol

Estrogen-progestogen contraceptives Estrogen-progestogen menopausal therapy

X-radiation, gamma-radiation

Dieldrin

Digoxin

Estrogen menopausal therapy Ethylene oxide Night shift work Polychlorinated biphenyls Tobacco smoking

Vulva

Human papillomavirus type 16

Human immunodeficiency virus type 1

Human papillomavirus types 18, 33

Vagina

Diethylstilbestrol (exposure in utero) Human papillomavirus type 16

Human immunodeficiency virus type 1

Uterine cervix

Diethylstilbestrol (exposure in utero) Estrogen-progestogen contraceptives Human immunodeficiency virus type 1

Human papillomavirus types 16, 18, 31, 33, 35, 39, 45, 51,52, 56, 58, 59 Tobacco smoking

Human papillomavirus types 26, 53, 66, 67, 68, 70, 73, 82

Endometrium

Estrogen menopausal therapy

Diethylstilbestrol

Classifications_by_cancer_site.pdf

', 'código do vídeo', '', 3, 407, 'tag', '2020-03-20');